TRT and feeling great: what the science says vs. the hype

What did @popethecoach actually say?

Donovan is 32 weeks into testosterone replacement therapy and reporting that he now feels "normal," which he defines as sleeping, eating, and functioning the way he's supposed to. Before TRT, he says he had low testosterone confirmed by testing, and struggled with fatigue, depression, poor sleep, and general dysfunction. He also notices increased body and facial hair growth, and credits switching to a new clinic with a "proper protocol" for his improvements. He ends by encouraging viewers to get their levels checked and offers to help people in his comments.

This is a personal experience video, not a medical claim. He isn't prescribing anything. He's describing symptom relief after a diagnosed deficiency was treated. That context matters a lot when evaluating what he's saying.

Does the science back this up?

Mostly, yes. The symptoms he described before starting TRT, specifically fatigue, depression, poor sleep, and impaired daily functioning, are well-documented features of hypogonadism. The improvements he's reporting are also consistent with what the literature shows, though the timeline and magnitude vary significantly between patients.

A 2018 systematic review by Buvat et al. in the Journal of Sexual Medicine confirmed that testosterone therapy in men with confirmed hypogonadism improves mood, energy, and overall quality of life. The TRAVERSE trial (Lincoff et al., 2023, New England Journal of Medicine), the largest cardiovascular safety trial of TRT to date, also documented patient-reported improvements in sexual function and energy in hypogonadal men on therapy. On the hair side, androgens drive terminal hair growth on the body and face via activation of follicular androgen receptors. Increased hair on the chest, stomach, back, and a fuller beard at week 32 is a predictable androgenic effect, not a surprise finding.

The 10-out-of-10 mood rating is harder to evaluate scientifically since that's a subjective self-report, but it's not implausible given his baseline.

What did they get wrong (or right)?

Donovan gets more right than wrong here. He correctly identifies that his testosterone was low before starting, he got tested, he's working with a clinic, and he frames this as his personal experience rather than universal advice. That's the responsible version of this kind of content.

The nerve-hit comment is worth addressing. He says rubbing the area and waiting a few hours will resolve it. This is reasonable first-aid advice for minor injection discomfort or a superficial nerve graze, but a true sciatic nerve injury from an injection requires medical evaluation, not just a massage. To his credit, he doesn't minimize the situation entirely, but viewers who experience numbness, shooting pain down the leg, or weakness after an injection should call their provider, not just wait it out.

His call to action, "comment TRT if you need help," is a soft gray area. He isn't diagnosing or prescribing, but directing symptomatic people toward himself rather than exclusively toward a licensed provider is worth flagging. Low testosterone symptoms overlap with thyroid disorders, sleep apnea, depression, and other conditions that require actual clinical evaluation.

What should you actually know?

If you relate to his pre-TRT symptom list, fatigue, depression, poor sleep, and low drive, getting a blood test is genuinely the right first step. Total testosterone, free testosterone, LH, FSH, and a basic metabolic panel are usually the starting point. However, symptoms alone don't indicate TRT is the right treatment. A diagnosis of hypogonadism requires both low serum testosterone on at least two morning measurements and clinical symptoms, per Endocrine Society guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism).

TRT is not a wellness upgrade for men with normal testosterone levels. The evidence for benefit is strongest in men with confirmed deficiency. Using it without a deficiency carries real risks including erythrocytosis, suppression of endogenous testosterone production, and potential fertility impact.

• Injections carry a small but real risk of nerve injury, infection, and hematoma. Technique and injection site matter.
• Hair growth changes, as Donovan describes, are a known androgenic effect. Scalp hair loss can also accelerate in genetically predisposed men on TRT.
• Week 32 is still relatively early. Many TRT effects, particularly on bone density and body composition, take 12 to 24 months to fully manifest.